<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>11(9)</volume><submitter>Diaz-Alberola I</submitter><pubmed_abstract>&lt;h4>Background and aims&lt;/h4>Common variable immunodeficiency (CVID) comprises a group of diseases with heterogeneous clinical and immunological manifestations. Several mutations have been identified in genes encoding proteins essential for immune function. Our aim was to phenotypically and genotypically characterize a patient diagnosed with CVID and study his response to the SARS-CoV-2 vaccine.&lt;h4>Methods&lt;/h4>We performed a next-generation sequencing analysis, a CMIA, and an ELISA to analyze the humoral and cellular response to the SARS-CoV-2 vaccine, respectively. We also employed flow cytometry and immunoturbidimetry to assess the patient's global immune status.&lt;h4>Results&lt;/h4>We found a low humoral but positive cellular response to the SARS-CoV-2 vaccine. NGS screening revealed a transi</pubmed_abstract><journal>Journal of clinical medicine</journal><pagination>2303</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9101713</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Common Variable Immunodeficiency Associated with a De Novo &lt;i>IKZF1&lt;/i> Variant and a Low Humoral Immune Response to the SARS-CoV-2 Vaccine.</pubmed_title><pmcid>PMC9101713</pmcid><pubmed_authors>Aguilera-Franco M</pubmed_authors><pubmed_authors>Sampedro A</pubmed_authors><pubmed_authors>Garcia-Aznar JM</pubmed_authors><pubmed_authors>Ganoza-Gallardo C</pubmed_authors><pubmed_authors>Lopez-Nevot MA</pubmed_authors><pubmed_authors>Diaz-Alberola I</pubmed_authors><pubmed_authors>Espuch-Oliver A</pubmed_authors><pubmed_authors>Jimenez P</pubmed_authors></additional><is_claimable>false</is_claimable><name>Common Variable Immunodeficiency Associated with a De Novo &lt;i>IKZF1&lt;/i> Variant and a Low Humoral Immune Response to the SARS-CoV-2 Vaccine.</name><description>&lt;h4>Background and aims&lt;/h4>Common variable immunodeficiency (CVID) comprises a group of diseases with heterogeneous clinical and immunological manifestations. Several mutations have been identified in genes encoding proteins essential for immune function. Our aim was to phenotypically and genotypically characterize a patient diagnosed with CVID and study his response to the SARS-CoV-2 vaccine.&lt;h4>Methods&lt;/h4>We performed a next-generation sequencing analysis, a CMIA, and an ELISA to analyze the humoral and cellular response to the SARS-CoV-2 vaccine, respectively. We also employed flow cytometry and immunoturbidimetry to assess the patient's global immune status.&lt;h4>Results&lt;/h4>We found a low humoral but positive cellular response to the SARS-CoV-2 vaccine. NGS screening revealed a transi</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-20T03:04:56.005Z</modification><creation>2024-11-15T05:02:52.8Z</creation></dates><accession>S-EPMC9101713</accession><cross_references><pubmed>35566429</pubmed><doi>10.3390/jcm11092303</doi></cross_references></HashMap>